Final-Program-ATS-2023-AP.vp

TUESDAY • MAY 23

285

2:25 CON: Formal Testing for Abnormal Acid Reflux Should Be Performed in All Patients with IPF to Determine the Need for Anti-Reflux Therapy A. Wilson, MD, FRCP, Norfolk, UK 2:35 PRO: Change in FVC at 3 Months is an Acceptable Primary Endpoint for IPF Clinical Trials Tamera Corte, MBBS, BScM, FRACP, PhD, Sydney, Australia 2:45 CON: 2. Change in FVC at 3 Months is an Acceptable Primary Endpoint for IPF Clinical Trials R.G. Jenkins, BM, MD, MRCP(UK), PhD, London, United Kingdom 2:55 PRO: BAL for Lymphocytosis Should be Performed in Patients with New Onset Fibrotic ILD T. Kulkarni, MD, MPH, Birmingham, AL 3:05 CON: 3. BAL for Lymphocytosis Should Be Performed in Patients with New Onset Fibrotic ILD N. Chaudhuri, MBChB, PhD, Ulster , Ireland 3:15 PRO: IPF is a Disease of the Recent Past G. Raghu, MD, Seattle, WA 3:25 CON: IPF is a Disease of the Recent Past J. Behr, MD, Munchen, Germany 3:35 Question and Answer This session and the International Conference are supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. All CME sessions have been planned and implemented in accordance with the Accreditation Criteria of the Accreditation Council for Continuing Medical Education (ACCME®) and are free of the control of ineligible companies (formerly commercial interests).

3:19 Comorbidity Screening in COPD: Challenges and Opportunities J. Bon, MD, MS, ATSF, Pittsburgh, PA 3:33 Panel Discussion N. Putcha, BA, MD, Baltimore, MD This session and the International Conference are supported by an independent medical educational grant from AstraZeneca LP. All CME sessions have been planned and implemented in accordance with the Accreditation Criteria of the Accreditation Council for Continuing Medical Education (ACCME®) and are free of the control of ineligible companies (formerly commercial interests). BASIC • BEHAVIORAL • CLINICAL • TRANSLATIONAL CLINICAL TOPICS IN PULMONARY MEDICINE CME Credits Available: 1.5 PRO/CON: HOT TOPICS IN INTERSTITIAL LUNG DISEASE Assemblies on Clinical Problems; Behavioral Science and Health Services Research 2:15 PM - 3:45 PM Walter E. Washington Convention Center Ballroom C (Level 3) Target Audience Clinicians, researchers, trainees and industry stake-holders interested in interstitial lung disease Objectives At the conclusion of this session, the participant will be able to: • analyze and understand IPF clinical trial results and endpoints and how these affect clinical practice and future research efforts • integrate available data on formal testing and treatment of gastroesophageal reflux in progressive fibrotic lung disease in to clinical practice • gauge the risks and potential benefits of bronchoalveolar lavage for patients with fibrotic lung disease This session will feature PRO/CON debates on 4 topics in ILD that are relevant to cutting edge clinical practice and research. These will include the utility of bronchoalveolar lavage in fibrotic lung disease, change in FVC over 3 months as a clinical trial endpoint in IPF, formal testing for acid reflux in progressive pulmonary fibrosis, and whether IPF is an entity of the past. Chairing: S. Montesi, MD, Boston, MA G. Raghu, MD, Seattle, WA 2:15 PRO: Formal Testing for Abnormal Acid Reflux Should Be Performed in All Patients with IPF to Determine the Need for Anti-Reflux Therapy M.B. Scholand, MD, Salt Lake City, UT C83

CLINICAL CRITICAL CARE TRACK

CME Credits Available: 1.5 MOC Points Available: 1.5

C84

CARDIAC ARREST: NEW SCIENCE AND CHANGING GUIDELINES

Assembly on Critical Care 2:15 PM - 3:45 PM Walter E. Washington Convention Center Room 150 A-B (Street Level) Target Audience Clinicians who treat patients experiencing in-hospital or out-of-hospital cardiac arrest or who are interested in the latest evidence and clinical practice standards on this topic Objectives At the conclusion of this session, the participant will be able to: • understand the evidence (or in some cases lack thereof) behind current cardiac arrest and post-arrest treatment guidelines

ATS 2023 • Washington, DC